Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
patient death
Biotech
Neurogene details death in Rett syndrome gene therapy trial
The biotech recommends using lower AAV doses and monitoring patients for the serious inflammatory condition that caused the patient's death.
Darren Incorvaia
May 16, 2025 3:00pm
Patient put in critical condition by Neurogene gene therapy dies
Nov 22, 2024 3:57am
Patient death prompts Roche to adjust Alzheimer's trial
Oct 30, 2024 11:40am
Kezar suspends key lupus study after 4 deaths
Sep 30, 2024 11:23am
Oncternal stock sinks 60% amid layoffs, trial terminations
Sep 12, 2024 10:51am
FDA places hold on Zentalis’ WEE1 drug after two sepsis deaths
Jun 18, 2024 8:21am
